WOS: 000076558000006PubMed ID: 9811387Elevated urinary calcium and phosphate excretion have been observed in children with insulin-dependent diabetes mellitus (IDDM). This may be related to a defect in tubular reabsorption. It is well known that converting enzyme inhibition decreases microalbuminuria and may prevent or retard diabetic nephropathy. We investigated whether enalapril also improves the defect in calcium and phosphate reabsorption, We studied 16 children and young adults (age 12-21 years) with IDDM and persistent microalbuminuria before and during 12 weeks of enalapril treatment. Before treatment microalbuminuria, urinary calcium excretion, and fractional tubular phosphorus reabsorption (TPR) were 153+/-53 mu g/min, 5.5+/-0.9 mg...
Several studies during the past 15 years have shown that antihypertensive therapy with different typ...
WOS: 000341298100018PubMed ID: 25010195Hyperglycemia, hypertension, dyslipidemia, and inflammation h...
Effect of enalapril and losartan on proteinuria in type 2 diabetic nephropathy patient
WOS: 000083179000004PubMed ID: 23902355Recent studies in diabetic humans have shown that angiotensin...
A double blind crossover trial was performed on the effect of enalapril on urinary albumin excretion...
Chronic renal failure (CRF) is almost always associated with high arterial blood pressure. Adequate ...
We evaluated the effects of angiotensin converting enzyme inhibition upon the urinary excretion of a...
The effect of enalapril and low prednisone doses on the urinary protein electrophoretic pattern was ...
Alterations in calcium metabolism can be demonstrated in the course of insulin-dependent diabetes me...
Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy.Ba...
Differential effects of calcium channel blockers on size selectivity of proteinuria in diabetic glom...
WOS: 000346268700003PubMed ID: 24941431Background: One of the major concerns is a nephropathy in dia...
Effects of antihypertensive drugs in experimental type 2 diabetes-related nephropathy.BackgroundIt h...
Background: One of the major concerns is a nephropathy in diabetes, which applies many different kin...
Abstract: In this study, we analyzed the effect of a therapeutic intervention in 46 enuretic childre...
Several studies during the past 15 years have shown that antihypertensive therapy with different typ...
WOS: 000341298100018PubMed ID: 25010195Hyperglycemia, hypertension, dyslipidemia, and inflammation h...
Effect of enalapril and losartan on proteinuria in type 2 diabetic nephropathy patient
WOS: 000083179000004PubMed ID: 23902355Recent studies in diabetic humans have shown that angiotensin...
A double blind crossover trial was performed on the effect of enalapril on urinary albumin excretion...
Chronic renal failure (CRF) is almost always associated with high arterial blood pressure. Adequate ...
We evaluated the effects of angiotensin converting enzyme inhibition upon the urinary excretion of a...
The effect of enalapril and low prednisone doses on the urinary protein electrophoretic pattern was ...
Alterations in calcium metabolism can be demonstrated in the course of insulin-dependent diabetes me...
Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy.Ba...
Differential effects of calcium channel blockers on size selectivity of proteinuria in diabetic glom...
WOS: 000346268700003PubMed ID: 24941431Background: One of the major concerns is a nephropathy in dia...
Effects of antihypertensive drugs in experimental type 2 diabetes-related nephropathy.BackgroundIt h...
Background: One of the major concerns is a nephropathy in diabetes, which applies many different kin...
Abstract: In this study, we analyzed the effect of a therapeutic intervention in 46 enuretic childre...
Several studies during the past 15 years have shown that antihypertensive therapy with different typ...
WOS: 000341298100018PubMed ID: 25010195Hyperglycemia, hypertension, dyslipidemia, and inflammation h...
Effect of enalapril and losartan on proteinuria in type 2 diabetic nephropathy patient